![Carolyn Beaty Scimemi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carolyn Beaty Scimemi
Keine laufenden Positionen mehr
Karriereverlauf von Carolyn Beaty Scimemi
Ehemalige bekannte Positionen von Carolyn Beaty Scimemi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FLEXION THERAPEUTICS, INC. | Compliance Officer | 12.09.2016 | 01.03.2022 |
General Counsel | 01.09.2016 | 01.03.2022 | |
DYAX CORP. | Compliance Officer | - | 01.01.2009 |
General Counsel | - | 01.01.2009 | |
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Compliance Officer | - | - |
General Counsel | - | - |
Ausbildung von Carolyn Beaty Scimemi
Suffolk University Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Compliance Officer | 3 |
General Counsel | 3 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Flexion Therapeutics, Inc.
![]() Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Oscient Pharmaceuticals Corp.
![]() Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Dyax Corp.
![]() Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Börse
- Insiders
- Carolyn Beaty Scimemi
- Erfahrung